Carcinoma del timo completamente resecado

1.    K. Kondo, Y. Monden, Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan, Ann Thorac Surg, 76 (2003), pp. 878–885
2.    C.D. Wright, J.C. Wain, D.R. Wong et al. Predictors of recurrence in thymic tumors: importance of invasion, World Health Organization histology, and size. J Thorac Cardiovasc Surg, 130 (2005), pp. 1413–1421
3.    F. Venuta, M. Anile, D. Diso et al. Thymoma and thymic carcinoma. Eur J Cardiothorac Surg, 37 (2010), pp. 13–25
4.    M. Okumura, H. Shiono, M. Inoue et al. Outcome of surgical treatment for recurrent thymic epithelial tumors with reference to World Health Organization histologic classification system. J Surg Oncol, 95 (2007), pp. 40–44
5.    H.K. Müller-Hermelink, P. Engel, T.T. Kuo et al. Tumours of the thymus: Introduction. W.D. Travis, E. Brambilia, H.K. Müller-Hermelink, C.C. Harris (Eds.), World Health Organization classification of tumours. Pathology and genetics: tumours of the lungs, pleura, thymus and heart, World Health Organization, Geneva, Switzerland (2004), pp. 148–151
6.    J. Huang, N.P. Rizk, W.D. Travis et al. Comparison of patterns of relapse in thymic carcinoma and thymoma. J Thorac Cardiovasc Surg, 138 (2009), pp. 26–31
7.    M. Hamaji, M.S. Allen, S.D. Cassivi et al. The role of surgical management in recurrent thymic tumors. Ann Thorac Surg, 94 (2012), pp. 247–254
8.    P. Ströbel, A. Bauer, B. Puppe et al. Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol, 22 (2004), pp. 1501–1509
9.    Y.L. Tseng, S.T. Wang, M.H. Wu, M.Y. Lin, W.W. Lai, F.F. Cheng. Thymic carcinoma: involvement of great vessels indicates poor prognosis. Ann Thorac Surg, 76 (2003), pp. 1041–1045
10.    F.C. Detterbeck, A.M. Parsons. Thymic tumors. Ann Thorac Surg, 77 (2004), pp. 1860–1869
11.    W.W. Lai, M.H. Wu, N.S. Chou, M.Y. Lin. Surgery for malignant involvement of the superior vena cava. J Formos Med Assoc, 91 (1992), pp. 991–995
12.    Y. Tsuchida, P. Therasse. Response evaluation criteria in solid tumors (RECIST): new guidelines. Med Pediatr Oncol, 37 (2001), pp. 1–3
13.    E.A. Eisenhauer, P. Therasse, J. Bogaerts et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer, 45 (2009), pp. 228–247
14.    J. Huang, F.C. Detterbeck, Z. Wang, P.J. Loehrer Sr. Standard outcome measures for thymic malignancies. J Thorac Oncol, 5 (2010), pp. 2017–2023
15.    Z.F. Mao, X.A. Mo, C. Qin, Y.R. Lai, M.L. Hackett. Incidence of thymoma in myasthenia gravis: a systematic review. J Clin Neurol, 8 (2012), pp. 161–169
16.    S. Suster, J. Rosai. Thymic carcinoma. A clinicopathologic study of 60 cases. Cancer, 67 (1991), pp. 1025–1032
17.    C.P. Hsu, C.Y. Chen, C.L. Chen et al. Thymic carcinoma. Ten years' experience in twenty patients. J Thorac Cardiovasc Surg, 107 (1994), pp. 615–620
18.    I.C. Okereke, K.A. Kesler, R.K. Freeman et al. Thymic carcinoma: outcomes after surgical resection. Ann Thorac Surg, 93 (2012), pp. 1668–1673
19.    B. Weksler, R. Dhupar, V. Parikh, K.S. Nason, A. Pennathur, P.F. Ferson. Thymic carcinoma: a multivariate analysis of factors predictive of survival in 290 patients. Ann Thorac Surg, 95 (2013), pp. 299–303
20.    Y.T. Yen, W.W. Lai, M.H. Wu et al. Thymic neuroendocrine carcinoma and thymoma are both associated with increased risk of extrathymic malignancy: a 20-year review of a single institution. Ann Thorac Surg, 91 (2011), pp. 219–225
21.    Y. Hosaka, M. Tsuchida, S. Toyabe, H. Umezu, T. Eimoto, J. Hayashi.Masaoka stage and histologic grade predict prognosis in patients with thymic carcinoma. Ann Thorac Surg, 89 (2010), pp. 912–917
22.    D. Blumberg, M.E. Burt, M.S. Bains et al. Thymic carcinoma: current staging does not predict prognosis. J Thorac Cardiovasc Surg, 115 (1998), pp. 303–309